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Abstract 1 
 2 
Objective: To assess the variables associated with complications of total hip replacement (THR) and 3 
report owner-assessed outcomes. 4 
Methods: Entries into the British Veterinary Orthopaedic Association-Canine Hip Registry (BVOA-5 
CHR) between September 2011 and December 2012 were reviewed separately and in conjunction with 6 
previous data (January 2010 – August 2011). An outcomes assessment questionnaire was used to 7 
collect data from owners. 8 
Results: Incidence of surgeon and owner reported complications were 8.2% and 4.3% respectively.  9 
THR using the Biomedtrix BFX® cup/stem prosthesis had a greater incidence of complications 10 
compared to THR using the Biomedtrix CFX® cup/stem prosthesis (p=0.002); complications were 4.48 11 
times more likely when using the Biomedtrix BFX® cup/stem prosthesis versus the Biomedtrix CFX® 12 
cup/stem prosthesis. THR using the Biomedtrix BFX® cup/stem prosthesis had a higher incidence of 13 
complications compared to THR using a hybrid prosthesis (Biomedtrix BFX® cup/CFX® stem, 14 
Biomedtrix CFX® cup/BFX® stem) (p=0.046); complications were 2.85 times more likely when using 15 
the Biomedtrix BFX® cup/stem prosthesis versus a hybrid prosthesis.  In 95% of cases, owner 16 
satisfaction with the outcome of THR was ‘very good’ or ‘good’. 17 
Conclusions: Complication rates from the BVOA-CHR are similar to previous studies.  The data 18 
suggest that prosthesis type is associated with complication rate, with BioMedtrix BFX® (circa 2012) 19 
having a high short-term complication rate.  20 
Introduction 21 
 22 
The BVOA-CHR (British Veterinary Orthopaedic Association-Canine Hip Registry 23 
http//:www.caninehipreplacement.org), hosted at the University of Liverpool Veterinary School, is an 24 
online database established in January 2010 (Forster and others 2012). The aim of the registry is to 25 
collate data from multiple veterinary referral clinics regarding techniques and complications associated 26 
with canine total hip replacement (THR) through surgeon-based registration of cases, informed owner 27 
consent, and prospective outcomes assessment using a client-administered online clinical metrology 28 
instrument. The BVOA-CHR offers an ongoing follow-up on all cases submitted, whereby surgeons are 29 
encouraged to document complications as and when necessary, months or even years after surgery.  30 
A previous report by Forster and others (2012) describes 170 cases of THR.  Continued submission of 31 
complications associated with these cases can occur and therefore enables long-term complications of 32 
THR to be reported. 33 
 34 
THR is a successful surgical treatment for debilitating conditions of the coxofemoral joint, providing high 35 
success and low complication rates.  Success rates for either cemented or cementless THR have been 36 
reported at 80% to 98% based on both clinical and radiographic evaluation of pain status and 37 
functionality, and owner assessment (Olmstead and others 1983, Olmstead 1987, DeYoung and others 38 
1992, DeYoung and others 1993, Massat and Vasseur 1994, Olmstead 1995, Marcellin-Little and others 39 
1999, Skurla and others 2000).  Previous results obtained from the BVOA-CHR revealed that in 94% 40 
of cases owners described their satisfaction with the outcome of THR as “very good” or “good” (Forster 41 
and others, 2012). 42 
 43 
Commercial systems are available for both cemented and cementless total hip replacement 44 
components.  Currently commonly used implants in the United Kingdom include the cemented fixation 45 
Biomedtrix CFX® cup/stem (BioMedtrix, LCC, Boonton, NJ) and cementless fixation Biomedtrix BFX® 46 
cup/stem (BioMedtrix, LCC, Boonton, NJ), Helica (Innoplant veterinary, Hannover, Germany) and Kyon 47 
(Kyon Pharma, Inc., Zurich, Switzerland).  Cemented fixation relies on a mantle of 48 
polymethylmethacrylate bone cement acting as a sealant between the implant and the bone.  The CFX® 49 
system provides a consistent fit regardless of femoral size and allows immediate prosthesis fixation.  50 
Cementless systems rely upon osseointegration in order to achieve fixation.  Cementless THR have 51 
reported similar complication rates to that of cemented prostheses (DeYoung 1992, DeYoung and 52 
others 1993, Guerrero and Montavon 2009). Using a combination of cemented femoral and cementless 53 
acetabular components has been described as an alternative to either entirely cemented or cementless 54 
implantation. (Minto and others 2011, Gemmill and others 2011). 55 
 56 
Complication rates after THR usually range between 5 and 20% although different rates have been 57 
described owing to the wide variety of systems used in different populations (Olmstead 1995, Olmstead 58 
1995, Edwards and others 1997, Guerrero and Montavon 2009, Gemmill and others 2011). 59 
Complications previously reported using data obtained from the BVOA-CHR included luxation, femoral 60 
fracture, minor wound dehiscence, wound sepsis, protrusio acetabuli, acetabular cup displacement, 61 
suspected pulmonary thromboembolism and death at end of surgery, femoral pain, femoral subsidence 62 
and sciatic paresis (Forster and others, 2012).  Other major complications include aseptic loosening, 63 
septic loosening, femoral medullary infarction and patellar luxation. (Massat and Vasseur 1994, 64 
Marcellin-Little and others 1999, Ota and others 2005, Bergh and others 2006, Marsolais and others 65 
2009).   66 
 67 
While a handful of studies reporting each system individually and their success and complication rates 68 
are available, the case numbers remain relatively small.  Using data obtained from the BVOA-CHR, our 69 
aims were (i) to identify any significant association or correlation between patient background variables 70 
(age, body weight, breed, and sex) and surgical variables (indication for surgery, prosthesis used), and 71 
the incidence of complications; and (ii) using the Liverpool Osteoarthritis in Dogs (LOAD) (Hercock and 72 
others 2009, Walton and others 2013) scores from an owner-assessed outcomes questionnaire, to 73 
report the owner-assessed outcome of THR. 74 
 75 
Materials and Methods 76 
 77 
The structure and workings of the BVOA-CHR have been previously described (Forster and others, 78 
2012). Briefly, information on each THR was submitted on a Microsoft Sharepoint site. Complications 79 
were submitted separately and were cross-referenced to the original surgery by the registry 80 
administrator.  Complications were categorised as ‘catastrophic’, ‘major’ and ‘minor’ according to the 81 
definitions of Cook and others (2010).  Participating surgeons signed a confidentiality disclosure 82 
agreement (CDA) with the University of Liverpool Veterinary School stating that the variables of 83 
“surgeon” or “clinic” would not be used in data analyses.  Participating surgeons were encouraged to 84 
submit all operated cases to the BVOA-CHR. 85 
 86 
Records of the BVOA-CHR database between September 2011 and December 2012 were exported to 87 
an Excel spreadsheet (Microsoft Excel 2011, Microsoftand reviewed.  A total of 140 THR cases were 88 
analysed with 136 cases meeting the inclusion criteria for the study; 4 cases were unavailable for the 89 
use because of inaccurate or missing data on the database.  These cases were collated with 170 90 
records of the BVOA-CHR database between January 2010 and August 2011 (Forster and others, 91 
2012), resulting in a total of 306 cases. 92 
 93 
Complications could also be submitted by the owner, via a questionnaire.  The same online owner-94 
administered outcomes assessment questionnaire was used as previously reported (Forster and others 95 
2012); a questionnaire modified from the ‘Liverpool Osteoarthritis in Dogs’ (LOAD) clinical metrology 96 
instrument (Walton and others 2013). Briefly, the questionnaire was divided into four sections.  Section 97 
A was composed of 10 questions and assessed information regarding the length of on-going mobility 98 
problems, medications received, and other concurrent medical history unrelated to hip dysplasia.  99 
Section B was composed of 13 questions and assessed activity and willingness to exercise before THR.  100 
Section C was composed of three questions and assessed whether unilateral or bilateral THR was 101 
carried out, overall owner satisfaction, and complications reported.  Finally, section D was composed 102 
of 13 questions and assessed activity and willingness to exercise after THR.  Questions and scoring 103 
were identical in sections B and D enabling a pre- and post-THR lameness score to be calculated.  The 104 
complete questionnaire was sent to cases where the date of surgery was between September 2011 105 
and December 2012 (Group One, < 16 month follow up), whereas a modified follow-up questionnaire 106 
containing only sections C and D was sent to cases where the date of surgery was prior to September 107 
2011 (Group Two, 17 - 36 month follow up).  For those cases without a contact email address, the 108 
questionnaire was sent via postal service. 109 
 110 
Statistical Analysis 111 
 112 
The dataset was reviewed and checked for coding of all variables. Descriptive statistics were calculated 113 
for each variable and data were analysed using software (SPSS Inc. SPSS Statistics for Mac, Version 114 
20.0. Armonk, NY: IBM Corp). Statistical significance was set at P<0.05. Associations between each 115 
variable and the incidence of complications were assessed using logistic regression analysis. 116 
Univariable binomial logistic regression was used to calculate measures of strength of association for 117 
each variable with the presence of complications.  A Mann Whitney U-test was performed using the 118 
SPSS statistical software package to assess the significance of total lameness scores before and after 119 
THR and between groups. 120 
 121 
Results 122 
 123 
One hundred and thirty six THR cases met the inclusion criteria and were reported by veterinarians via 124 
online submission (September 2011 – December 2012).  These new reports were collated with those 125 
previously reported, resulting in a 306 cases (Forster and others 2012) (January 2010 – August 2011). 126 
 127 
Cases were recorded by twenty-four veterinary surgeons from twenty small animal clinics within the 128 
United Kingdom.  The average case contribution per surgeon was 12.75 cases (range; 1- 41 129 
cases/surgeon).  Dogs ranged from less than 1 year to 12 years of age (mean ± SD, 3.38 ± 2.86 years), 130 
with 39% of dogs being less than two years old, and weighing 4.00–72.00 kg (mean, 28.47kg ± 10.80 131 
kg). There were 129 female (40 intact, 89 neutered) and 177 male dogs (110 intact, 67 neutered). The 132 
Labrador Retriever (n = 91), German Shepherd dog (n = 43), Crossbreed (n = 39), Border Collie (n = 133 
27), Golden Retriever (n = 16), Rottweiler (n = 13), English Springer Spaniel (n = 11), West Highland 134 
White Terrier (n = 10) and Cocker Spaniel (n = 7) were the most frequently represented breeds.  135 
Indications for surgery included hip dysplasia and osteoarthritis (n = 268), recurrent luxation (13), 136 
avascular necrosis of the femoral head (8), Legg-Calvé-Perthes disease (7), fracture (7), and traumatic 137 
luxation (3).  Surgical implants included BioMedtrix CFX cup/stem (n = 140), BioMedtrix hybrid (n = 74); 138 
using BioMedtrix BFX cup and CFX stem (n = 68) or BioMedtrix CFX cup and BFX stem (n = 6), 139 
BioMedtrix BFX cup/stem (n = 39), Helica (n = 34) and Kyon (n = 19).  Thirty-nine dogs underwent 140 
bilateral staged THR. 141 
 142 
Complication Rate 143 
 144 
The BVOA-CHR data collected since January 2010 (306 cases) was combined with information on the 145 
incidence of complication, treatment and outcome gained from owner completion of their questionnaire. 146 
 147 
The incidence of surgeon-reported surgical complication was 8.2%. The incidence of owner-reported 148 
complications was 4.3%.  Complications (comprising of those reported by owner and/or veterinary 149 
surgeon) included luxation (n = 11), femoral fracture (9; 7 postoperative cases, 2 intraoperative cases), 150 
problems associated with wound healing (9), aseptic loosening (6), acetabular fracture (2), sciatic 151 
paresis (1), femoral pain (1), femoral subsidence (1), protrusio acetabuli (1) and cardiac arrest 152 
(suspected pulmonary thromboembolism) (1) (Table 1.).  Two catastrophic complications occurred; 153 
cardiac arrest in a case with hybrid fixation (BFX cup/CFX stem), and femoral fissure that led to 154 
euthanasia in a Kyon case (Table 2.).  Three minor complications occurred which were all associated 155 
with the CFX cup/stem prosthesis.  These included sciatic pain, femoral pain and protrusio acetabuli. 156 
The remaining complications (n=37) were classified as major, requiring additional surgical or medical 157 
treatment.  Five cases of explantation were classified as major complications based on this classification 158 
system. 159 
 160 
Eleven cases of luxation were reported (2 BFX cup/stem, 5 CFX cup/stem, 1 CFX cup/BFX stem, 2 161 
Helica, 1 Kyon).  Luxation was reported at 0 (n=2), 8, 10, 18, 57, 235, 300 and 302 days.  In two cases 162 
the time of luxation was not specified.  In one case the hip had luxated during postoperative radiography; 163 
excision of new bone formation, which was causing ventral impingement followed by reduction resulted 164 
in a successful outcome. Two cases resulted in explantation; in one of these cases the hip had reluxated 165 
on two occasions (302 days and 363 days).  One case was managed with closed reduction and Ehmer 166 
sling application.  The remaining cases were managed via open reduction with either the same sized 167 
implant or an increased femoral head/neck length. 168 
 169 
Three cases of aseptic loosening were reported by the veterinary surgeon and three cases by the owner 170 
(4 Helica, 2 BFX cup/stem).  Veterinary surgeons reported aseptic loosening at 147, 202 and 418 days 171 
postoperatively, all of these occurred using the Helica prosthesis.  Three cases of aseptic loosening 172 
were reported by the owner to have occurred in the first three months following surgery (2 BFX 173 
cup/stem, 1 Helica). Revision surgery was carried out in four cases and THR explantation in two cases. 174 
 175 
Nine femoral fractures were reported (5 BFX cup/stem, 1 CFX cup/stem, 1 BFX cup/CFX stem, 2 Kyon); 176 
7 cases of postoperative femoral fracture and 2 cases of intraoperative femoral fracture or fissure 177 
formation.  On both occasions where the fracture occurred intraoperatively (1 CFX cup/stem, 1 BFX 178 
cup/stem), successful repair was carried out using cerclage wire alone, without explantation.  Femoral 179 
fracture occurred 17 days after surgery using the Kyon prosthesis; the animal was euthanased.  A 180 
further 6 cases of femoral fracture were reported, of which 5 (3 BFX cup/stem, 1 BFX cup/CFX stem, 1 181 
Kyon) were treated successfully and 1 case (BFX cup/stem) required explantation.  Femoral fracture 182 
occurred in 7 cases, which used a cementless femoral prosthesis (5 BFX cup/stem, 2 Kyon), and 2 183 
cases using a cemented femoral prosthesis (1 CFX cup/stem, 1 BFX cup/CFX stem). 184 
 185 
When accounting for all complications, ten cases that had complications were identified with the CFX 186 
cup/stem prosthesis (10/140, 7.1%), 10 with the BFX cup/stem prosthesis (10/39, 25.6%), 8 with a 187 
hybrid prosthesis (8/74, 10.8%), 6 with the Helica prosthesis (6/34, 17.6%) and 4 with the Kyon 188 
prosthesis (4/19, 21.1%) (Table 3).  In some cases, more than one type of complication occurred (n=3, 189 
Table 1 and 2).  However, statistical analysis was completed on the basis of whether the case had a 190 
complication, be that one or several (Table 3).  No statistical significance was identified between weight, 191 
age, gender, breed nor indication for THR and the incidence of complications.  A relationship between 192 
prosthesis and the occurrence of complications (inclusive of catastrophic, major and minor 193 
complications) was identified.  THR using the BFX cup/stem prosthesis had a significantly different 194 
incidence of complications compared to THR using the CFX cup/stem prosthesis (p=0.002).  A 195 
complication was 4.48 times more likely to occur when using the BFX cup/stem prosthesis versus the 196 
CFX cup/stem prosthesis.  THR using the BFX cup/stem prosthesis had a significantly different 197 
incidence of complications compared to THR using a hybrid prosthesis (p=0.046).  A complication was 198 
2.85 times more likely to occur when using the BFX cup/stem prosthesis versus a hybrid prosthesis.  Of 199 
the complications which occurred using hybrid prosthesis, 7/8 complications used a BFX cup/CFX stem 200 
combination.   Complications included fracture of the acetabulum (n=2), wound infection (n=3), cardiac 201 
arrest (n=1) and femoral fracture (n=1).  One case of luxation occurred with the use of a CFX cup/BFX 202 
stem prosthesis.  No significant difference in complication rate was found between any of the other 203 
prosthetic types. 204 
 205 
Owner Assessment Questionnaire 206 
 207 
Group One (136 cases, < 16 month follow up) 208 
 209 
A total response rate of 55% was achieved for group one via the online owner assessment 210 
questionnaire.  11% dogs were reported as ‘not at all disabled’ by their lameness before THR.  A total 211 
of 43% dogs were considered lame by owner assessment for 0-6 months before THR, whereas 25% 212 
were lame for 6-12 months, and 32% for more than 12 months before surgery.  In the last month before 213 
surgery 59% of dogs were receiving 0-1 mile of exercise per day before THR, whereas 25% received 214 
1-2 miles of exercise, and 16% received more than 2 miles of exercise.  Of these, 34% received mainly 215 
off-lead exercise, whereas 66% received mainly on-lead exercise. 216 
 217 
In 81% of cases, owners described their satisfaction with the outcome of THR as ‘very good’, 14% as 218 
‘good’, 1% as ‘fair’ and 4% as ‘poor’.  No owners rated their satisfaction as ‘very poor’. There was no 219 
significant difference in owner assessed lameness scores between those dogs that had undergone 220 
unilateral THR and those that had undergone bilateral THR (preoperatively; p=0.30, postoperatively; 221 
p=0.61).  There was a statistically significant difference in owner assessed lameness scores before and 222 
after THR (p<0.001) with the mean LOAD score before and after THR being 22/52 and 6/52, 223 
respectively. 224 
 225 
Group Two (170 cases, 17 - 36 month follow up) 226 
 227 
85% of owners that had originally responded to the questionnaire within 24 months of surgery (1) also 228 
completed the follow-up questionnaire containing sections C and D only (<36 months following surgery).   229 
Three complications previously not reported by either the veterinary surgeon or the owner were 230 
identified, aseptic loosening (within 3 months following surgery, n=2, BFX cup/stem prosthesis) and 231 
luxation (n=1, CFX cup/stem prosthesis).  The time of luxation following surgery was not provided and 232 
contact with the owner to gain further information was unsuccessful. 233 
 234 
In 88% of cases, owners described their satisfaction with the outcome of THR as ‘very good’, 6% as 235 
‘good’, 5% as ‘fair’ and 1% as ‘very poor’.  No owners rated their satisfaction as ‘poor’. Owner-assessed 236 
lameness scores reported <24 months after THR and scores reported approximately one year later 237 
(<36 months after THR) were significantly different (p<0.01) with the mean LOAD score within 24 238 
months of THR being 5.6/52 and approximately one year later being 8.7/52.  However, the score 239 
reported <36 months after THR was still significantly lower than that reported prior to surgery 240 
(preoperative score 18.7/52, p<0.001). 241 
 242 
Discussion 243 
 244 
In 95% of cases, owners of animals that had surgery <24 months previously, described their satisfaction 245 
with the outcome of THR as ‘very good’ or ‘good’.  In 94% of cases, owners of animals that had had 246 
surgery <36 months previously, described their satisfaction with the outcome of THR as ‘very good’ or 247 
‘good’. The questionnaire was based on LOAD; a validated owner-completed clinical metrology 248 
instrument that is recommended for the measurement of canine osteoarthritis, which has documented 249 
‘criterion validity’ (correlation with force-platform data) (Walton and others 2013).  The LOAD scores 250 
reported both <24 months and <36 months after THR were significantly lower than those reported prior 251 
to surgery (p<0.001).  Seemingly, there is a high degree of owner satisfaction up to 36 months following 252 
THR.  We appreciate that reliance on owner perception of lameness is not always reliable (Soderman 253 
2000), and that owner interpretation of lameness or the term ‘disabled’ may differ from that of a 254 
veterinary surgeon.  Interestingly, 11% of cases were reported as ‘not disabled’ by the owner prior to 255 
THR.  The potential that these animals received surgery due to radiographic assessment alone and 256 
without overt clinical signs of lameness or pain exists.  However, owners’ opinion regarding the ability 257 
to ambulate is somewhat unreliable, especially when considering cases where bilateral pelvic limb 258 
lameness is present.  Also, a large proportion of dogs are non-surgically managed via exercise 259 
restriction prior to surgery, and therefore interpretation of lameness by the owner can be difficult. 260 
 261 
Dogs ranged from less than one year to 12 years of age (mean ± SD, 3.38 ± 2.86 years), with 39% of 262 
dogs being less than two years old.  A substantial proportion of dogs undergoing THR are less than two 263 
years old.  In our opinion, prospective monitoring of the performance of THRs is of great importance if 264 
we are to assess the longevity and efficacy of this intervention.  Continued yearly reporting of the BVOA-265 
CHR will provide information on the success of THR prostheses in such young dogs. 266 
  267 
There was not a significant difference in owner-assessed lameness scores between those dogs that 268 
had undergone unilateral THR and those that had undergone bilateral THR (preoperatively; p=0.30, 269 
postoperatively; p=0.61).  However, due to the majority of cases not requiring bilateral surgery (8, 10), 270 
the statistical power of this assessment was limited and data for the degree of lameness (LOAD score) 271 
between the first and subsequent surgeries was lacking.   272 
 273 
Complication rates, gained from collating data from both the BVOA-CHR and owner assessment 274 
questionnaire, are similar to previously documented studies (Olmstead 1995, Edwards and others 1997, 275 
Guerrero and Montavon 2009, Gemmill and others 2011).   An apparent difference between 276 
complication rates reported by surgeons and those reported by owners was found, as previously 277 
reported by Forster and others (2012). Even though the complication rate reported by owners was lower 278 
than that reported by veterinary surgeons, 4.3% and 8.2% respectively, it was found that in some 279 
instances perioperative complications were reported by the owners and not by the veterinary surgeon.  280 
This could be due to inadequate data input by veterinary surgeons, the animal being represented to a 281 
different referral veterinary surgeon when the complication occurs or unreliable data input by the owner. 282 
 283 
A single case of protrusion acetabuli was reported. Protrusion acetabuli in this instance was classified 284 
as minor due to the lack of medical or surgical intervention reported, according to the definitions of Cook 285 
and others (2010).  It is probable that the complication was perceived to be one that could not be 286 
surgically resolved. 287 
 288 
The rate of aseptic loosening was 1.9%, similar to previously reported rates of 2.1% to 7.2% (Olmstead 289 
and others 1983, Massat and Vasseur 1994, Edwards and others 1997, Bergh and others 2006).  The 290 
postoperative complication rate of aseptic loosening is low suggesting that the mechanical failure of the 291 
implants, bearing surfaces or bone-implant/bone-cement interface is not a significant factor three years 292 
after canine THR. However, the reliance on both owners and veterinary surgeons to input data and the 293 
fact that cases of aseptic loosening have been described in the absence of clinical signs in dogs (Bergh 294 
and others 2006), means that the true incidence of aseptic loosening might be higher than reported 295 
herein. Owners might attribute a gradual deterioration in function to ‘natural changes post operatively’ 296 
and might not report changes to their veterinarian.   The majority of cases of aseptic loosening were 297 
reported within the first six months following surgery. Aseptic loosening can be the result of mechanical 298 
or biological loss of fixation over time, or inadequate initial fixation.  Evaluation criteria inclusive of the 299 
timing of imaging were not set for the identification of complications radiographically.  It remains 300 
impossible to discern whether early reports of stem loosening are due to inadequate initial fixation or 301 
subsequent loss of fixation. 302 
 303 
Subsidence of the femoral component can occur due to lack of osseous integration.  Predisposing 304 
factors can include straight femora which lack an isthmus or with undersized femoral implants (Rashmir-305 
Raven et al, 1992).  A single case of subsidence was reported.  This complication is under-reported 306 
when compared to other studies (Kidd SW, 2016). 307 
 308 
A study reporting complications of human total hip arthroplasty reported that the rate of acetabular 309 
loosening increased from 2% at six years postoperatively to 42% at 11 years postoperatively (Mulroy 310 
and Harris 1990). Therefore, for example the absence of aseptic implant loosening in 140 CFX patients 311 
in the current study, is likely underestimating the true incidence, which in addition is likely rising over 312 
time.  Cementless fixation of the acetabular component has become increasingly popular because the 313 
long-term results of cemented total hip have shown that late failure is associated with loosening of the 314 
acetabular component (Yee and others 2000, Skurla and James 2005, Bergh and others 2006). 315 
Interestingly, in the data reported in our study, aseptic loosening was reported with cementless 316 
prostheses only (BioMedtrix BFX cup/stem, Helica). It is possible that with longer follow-up times a 317 
different outcome may emerge such that cementless THR may result in longer survival and less aseptic 318 
loosening in comparison to cemented THR.  319 
 320 
Complications reported using cementless femoral stems include subsidence, intra-operative femoral 321 
(fissure) fractures and post-operative femoral fractures (Pernell and others 1995, Liska 2004, Dyce 322 
2005, McKee 2008).  Predisposing risk factors for fracture of the femur after THR include osteopathy 323 
and iatrogenic fissures created during surgery (Liska 2004).  Liska (2004) described an increased 324 
concentration of biomechanical forces at the distal end of the femoral stem as a plausible cause of 325 
femoral fracture. Cementless femoral fixation has been reported as a risk factor for femoral fracture for 326 
human total hip arthroplasty (Berend and others 2006).  However after a fracture, femoral component 327 
survivorship was greater for cementless stems compared to cemented stems.  Although the data is 328 
limited, overall it appears that many BFX complications relate to the femoral component, whereas the 329 
acetabular component is more reliable (McKee 2008). The results suggest BioMedtrix BFX has a high 330 
short-term complication rate, associated with the femoral stem.  Overall the incidence of femoral fracture 331 
(2.9%) was greater for cementless prosthesis (5 BFX cup/stem, 2 Kyon) compared to cemented 332 
implants (1 hybrid BFX cup/CFX stem, 1 CFX cup/stem). 333 
 334 
An overt limitation of this study is that surgeon experience is not analysed as a variable.    The ability 335 
to categorise surgeon experience is a difficult one; whether this is based on number of years as a 336 
registered specialist, years since completion of a certified hip replacement teaching course, number of 337 
cases submitted or number of cases carried out per surgeon/clinic per year. When using years of 338 
experience/cases carried out as a determination of skill, it would prove difficult when reviewing data 339 
over a period of time, based on the need to alter this with each subsequent year.  As detailed previously, 340 
during the initial set-up of the BVOA-CHR, participating surgeons signed a CDA with The University of 341 
Liverpool Veterinary School which is a legally binding agreement stating that the variables of “surgeon” 342 
or “clinic” will never be used in data analyses. In this way, we aimed to avoid any concerns caused by 343 
commercial sensitivities and to encourage data submission.  Despite this agreement, the potential for 344 
lack of reporting by surgeons due to the negative connotations of reporting postoperative complications 345 
cannot be overlooked. This and the fact that the task of reporting in itself is time consuming could alter 346 
input and therefore outcome following surgery. 347 
 348 
A noteworthy limitation of this study is that analysis of data is inclusive only of those surgeries occurring 349 
during or before December 2012.  This analysis therefore does not account for variations in prosthetic 350 
design subsequent to this point; for example the introduction of new generation BioMedtrix BFX femoral 351 
components (BFX Ti Plasma Spray Stem: 2012, BFX Ti EBM Stem: 2013).  It is clear that at this time 352 
point, the low number of cases of BFX, Helica and Kyon designs do not allow for further subcategorising 353 
and statistical analysis.  With ongoing collection and subsequent collation of data the number of cases 354 
per prosthetic type should increase the strength of further analyses. 355 
 356 
Conclusion 357 
 358 
There is owner satisfaction and a significant decrease in the LOAD score after THR, even when 359 
reported up to 36 months following THR.  Complication rates from the BVOA-CHR are similar to 360 
previous studies.  These first comparator results suggest a significant difference in complication rate 361 
with prosthesis type, with BioMedtrix BFX having a high short-term complication rate.  The results are 362 
not suggestive of an association between aseptic loosening and the use of a cemented prosthesis type. 363 
However, the follow up time is relatively short.   364 
  365 
Table 1.  Prosthetic type cross-tabulated with Complication Type.  Data recorded by surgeon or 366 
owner, January 2010 – December 2012 367 
 368 
 Acetabular 
Fracture 
Femoral Fracture Luxation Aseptic 
Loosening 
Wound 
Complications 
Other Total 
Complications 
Total 
Number 
of 
Cases 
Intraoperative Postoperative 
BFX - 1 4 2 2 3 1 13 39 
CFX - 1 - 5 - 2 3 11 140 
Hybrid 2 - 1 1 - 3 1 8 74 
Helica - - - 2 4 - - 6 34 
Kyon - - 2 1 - 1 - 4 19 
       42 306 
 369 
In some instances cases with complications had more than one type of complication i.e. Cases with 370 
complications = 38, Total Complications = 42  371 
Table 2.  Prosthetic type cross-tabulated with Complication Severity (25).  Data recorded by surgeon 372 
or owner, January 2010 – December 2012 373 
 374 
 Catastrophic 
Complications 
Major 
Complications 
Minor 
Complications 
Total 
Complications 
Total Number of 
Cases 
BFX - 13 - 13 39 
CFX - 8 3 11 140 
Hybrid 1 7 - 8 74 
Helica - 6 - 6 34 
Kyon 1 3 - 4 19 
    42 306 
 375 
In some instances cases with complications had more than one type of complication i.e. Cases with 376 
complications = 38, Total Complications = 42  377 
Table 3.  Prosthetic type cross-tabulated with Complication Occurrence.  Data recorded by surgeon or 378 
owner, January 2010 – December 2012 379 
 380 
 Number of Cases 
without 
Complications 
Number of Cases 
with Complications 
Total Number 
of Cases 
Complication 
Rate % 
BFX 29 10 39 25.6 
CFX 130 10 140 7.1 
Hybrid 66 8 74 10.8 
Helica 28 6 34 17.6 
Kyon 15 4 19 21.1 
 268 38 306 12.4 
 381 
In some cases, more than one type of complication occurred. However, statistical analysis was 382 
completed on the basis of whether the case had a complication, be that one or several.  383 
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